Literature DB >> 20857339

Understanding equivalence and noninferiority testing.

Esteban Walker1, Amy S Nowacki.   

Abstract

Increasingly, the goal of many studies is to determine if new therapies have equivalent or noninferior efficacies to the ones currently in use. These studies are called equivalence/noninferiority studies, and the statistical methods for their analysis require only simple modifications to the traditional hypotheses testing framework. Nevertheless, important and subtle issues arise with the application of such methods. This article describes the concepts and statistical methods involved in testing equivalence/noninferiority. The aim is to enable the clinician to understand and critically assess the growing number of articles utilizing such methods.

Mesh:

Year:  2010        PMID: 20857339      PMCID: PMC3019319          DOI: 10.1007/s11606-010-1513-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  13 in total

1.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.

Authors:  S S Ellenberg; R Temple
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

2.  Therapeutic equivalence: fallacies and falsification.

Authors:  Andrew D Garrett
Journal:  Stat Med       Date:  2003-03-15       Impact factor: 2.373

3.  Assessing equivalence: an alternative to the use of difference tests for measuring disparities in vaccination coverage.

Authors:  Lawrence E Barker; Elizabeth T Luman; Mary M McCauley; Susan Y Chu
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

4.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Douglas G Altman; Stuart J Pocock; Stephen J W Evans
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

5.  Quality of reporting of noninferiority and equivalence randomized trials.

Authors:  Anne Le Henanff; Bruno Giraudeau; Gabriel Baron; Philippe Ravaud
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

6.  Lessons from and cautions about noninferiority and equivalence randomized trials.

Authors:  Peter C Gøtzsche
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

7.  Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

Authors:  S Staszewski; P Keiser; J Montaner; F Raffi; J Gathe; V Brotas; C Hicks; S M Hammer; D Cooper; M Johnson; S Tortell; A Cutrell; D Thorborn; R Isaacs; S Hetherington; H Steel; W Spreen
Journal:  JAMA       Date:  2001-03-07       Impact factor: 56.272

8.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

9.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

Authors:  R Temple; S S Ellenberg
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

10.  Practical issues in equivalence trials.

Authors:  A F Ebbutt; L Frith
Journal:  Stat Med       Date:  1998 Aug 15-30       Impact factor: 2.373

View more
  166 in total

1.  Use your head! Perception of action possibilities by means of an object attached to the head.

Authors:  Jeffrey B Wagman; Alen Hajnal
Journal:  Exp Brain Res       Date:  2015-12-08       Impact factor: 1.972

2.  Radiological technologists' performance for the detection of malignant microcalcifications in digital mammograms without and with a computer-aided detection system.

Authors:  Rie Tanaka; Miho Takamori; Yoshikazu Uchiyama; Junji Shiraishi
Journal:  J Med Imaging (Bellingham)       Date:  2015-05-27

3.  The Disrupted Connectivity Hypothesis of Autism Spectrum Disorders: Time for the Next Phase in Research.

Authors:  Roma A Vasa; Stewart H Mostofsky; Joshua B Ewen
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

4.  Condensing parent training: A randomized trial comparing the efficacy of a briefer, more intensive version of Parent-Child Interaction Therapy (I-PCIT).

Authors:  Paulo A Graziano; Rosmary Ros-Demarize; Megan M Hare
Journal:  J Consult Clin Psychol       Date:  2020-04-30

5.  On Causal Inferences for Personalized Medicine: How Hidden Causal Assumptions Led to Erroneous Causal Claims About the D-Value.

Authors:  Sander Greenland; Michael P Fay; Erica H Brittain; Joanna H Shih; Dean A Follmann; Erin E Gabriel; James M Robins
Journal:  Am Stat       Date:  2019-05-20       Impact factor: 8.710

6.  Nicotine modulates human brain plasticity via calcium-dependent mechanisms.

Authors:  Jessica Grundey; Jerick Barlay; Giorgi Batsikadze; Min-Fang Kuo; Walter Paulus; Michael Nitsche
Journal:  J Physiol       Date:  2018-10-17       Impact factor: 5.182

7.  Breast density estimation from high spectral and spatial resolution MRI.

Authors:  Hui Li; William A Weiss; Milica Medved; Hiroyuki Abe; Gillian M Newstead; Gregory S Karczmar; Maryellen L Giger
Journal:  J Med Imaging (Bellingham)       Date:  2016-12-28

8.  The effectiveness of psychodynamic psychotherapies: An update.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

9.  Short and sweet: cardiovascular and metabolic improvements in just one hour per week.

Authors:  Robert F Bentley; Danielle C Bentley
Journal:  J Physiol       Date:  2015-06-01       Impact factor: 5.182

10.  A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods.

Authors:  Mohamed Zaid; Eugene J Koay; Nimit Bajaj; Ryan Mathew; Lianchun Xiao; Anshuman Agrawal; Pearl Fernandes; Hannah Burrows; Millicent A Roach; Christopher T Wilke; Caroline Chung; Clifton D Fuller; Jack Phan; G Brandon Gunn; William H Morrison; Adam S Garden; Steven J Frank; David I Rosenthal; Michael Andersen; Adegbenga Otun; Mark S Chambers
Journal:  Oral Oncol       Date:  2020-04-13       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.